Latest filing published 24 Aug 2023 for MIRA PHARMACEUTICALS, INC., €757k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -66.9%Entry US$6.38 · Close at T+365 US$2.11
- -66.4%Entry US$6.25 · Close at T+365 US$2.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
George Cappy: trading record in brief
All filings by George Cappy on record concern Mira Pharmaceuticals, Inc. Over a trading history stretching from 2 August 2023 to 7 August 2023, the count stands at 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €1.8M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 24 August 2023 came the latest disclosure, an open-market purchase for €757k in Mira Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to George Cappy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 119,048 shares@ US$7.0043.0% of flowCommon StockSEC:0000897069-23-001265:0Canonical exit: 5 Nov 2023 (T+90)
- 157,170 shares@ US$7.0057.0% of flowCommon StockSEC:0000897069-23-001091:0Canonical exit: 31 Oct 2023 (T+90)
2 of 2 declarations